Improvement in insulin sensitivity and prevention of high fat diet-induced liver pathology using a cxcr2 antagonist

HIGHLIGHTS

• who: Brett E. Phillips from the Institute of Cellular Therapeutics, Allegheny Health Network, th Floor South Tower, East North Pittsburgh, PA, USA have published the paper: Improvement in insulin sensitivity and prevention of high fat diet-induced liver pathology using a CXCR2 antagonist, in the Journal: (JOURNAL)
• what: In spite of the evidence linking neutrophils and CXCR2 to T2D and possibly T2D-associated NAFLD , to date there are no studies aimed at short-circuiting neutrophil function and neutrophil-driven inflammation independently of macrophages-well known participants in the progression of HFD pathology towards NAFLD/NASH . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.